Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial

Eli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world’s best-selling prescription medicine, AbbVie Inc’s Humira, in a late-stage trial.